Replies to post #22206 on Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

Steve, it's all about killing momentum. Tutes are largely on the sidelines in these types of biotech stocks, in terms of investing (which is true of most or all of ADXS's peers, such as ZIOP and ADRO). The tutes accumulate here and there, but as soon as they are done, the manipulators bring it right back down. So the stock price is basically being determined by traders, not investors buying or selling, and the traders are not playing the long side, due to the continued downtrend that the manipulators have manufactured. This will change. When the stock rallied from 5 to 30 in a matter of months, retail longs were convinced that it would never end. But it did. And so will this manipulated downtrend and suppression.

[samk]

you wrote:
"it's only worth how much people are willing to pay for it"
I do not know where you are coming from, but that is what short cabal wants investors to believe. And if you look at the trading pattern, you will see that 100 shares block selling persists through the entire day to drive stock down, or to keep it in check.
Based on the progress in science, trials and revenue prospects, ADXS should be trading in $30-40th now and it is in much better shape, than when it was running to $30 in 2015...
Go figure...
The entire market is crooked and the price of any stock depends on what powers want it to trade at given time.
ADXs is on the brink of explosion in a not so distant future
and will reward all patient shareholders...